In front of the U.S. House Ways and Means Subcommittee, Dr. Edgerton described how challenges of biosimilar costs threaten patient care and outlined several potential legislative solutions.
Calling Rheumatologist Leaders: AMA House of Delegates Opportunity
The ACR’s delegation to the American Medical Association House of Delegates is seeking ACR members who may be interested in serving as representatives to the Young Physician Section.
ACR Community Practice Council Becomes Independent Practice Subcommittee
The Community Practice Council has been renamed the Independent Practice Subcommittee and now operates as a subcommittee of the Committee on Rheumatologic Care. The group will continue its mission with an enhanced platform and visibility within the College’s governance framework.
FDA Approves Oral Solution of Colchicine to Prevent Gout Flare
The FDA approved an oral solution of colchicine for the prevention of gout flare in adults. Its dosage can be easily adjusted on the basis of patient needs.
Trends in the Use of DMARDs for Patients with JIA
Yalamanchili et al. describe how trends in disease-modifying anti-rheumatic drug (DMARD) use have evolved for insured, U.S. patients with juvenile idiopathic arthritis. Overall, the study found that from 2000 to 2022 in this patient population the use of biologic and targeted synthetic DMARDs rose, while the use of conventional synthetic DMARDs declined.
ACR Monitoring HHS Workforce Reductions, Function Consolidations
Changes announced April 1 will cut 10,000 positions at the U.S. Department of Health & Human Services and consolidate many department functions. The ACR is monitoring how these changes may impact regulatory issues of concern to ACR members.
New Communications & Marketing Committee Chair Gears Up to Amplify ACR’s Important Work
As the ACR’s megaphone, the Communications and Marketing Committee helps get clear and accurate information into the hands of those who need it, whether that’s clinicians, researchers, educators or patients, says chair Howard Yang, MD, RhMSUS.
RheumPAC Q1 Fundraising Update
First-quarter donations have put RheumPAC in great shape to help build a Congress that supports the needs of the rheumatology community. Consider joining your colleagues today in support of the ACR’s Congressional champions.
Looking Ahead to Advocates for Arthritis 2025
This May, more than 120 ACR leaders, fellows and patients with rheumatic disease will converge in Washington, D.C., to lobby Congress on issues including protecting Medicare and Medicaid, National Institutes of Health research funding and pharmacy benefit manager reform.
Betty P. Tsao, PhD, Becomes Chair of Journal Publications Committee
As chair of the ACR Journal Publications Committee, Dr. Tsao brings extensive experience with journals and many ideas about how to improve the submission and review process.
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 319
- Next Page »